Home / Products / Cancer (Tumor) Cell Lines / HT-1197
HT-1197
Datasheet Protocol

HT-1197

Cat. No. ARC0325
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Urinary bladder

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

HT-1197 is a cancer cell line of urinary bladder carcinoma (recurrent), isolated from in situ; urinary bladder.

Recommended Products

LARP4B Knockout SK-HEP-1 Polyclonal Cells LARP4B Knockout SK-HEP-1 Polyclonal Cells Cat. No. ARG16006 CDK6 Knockout HT29 Polyclonal Cells CDK6 Knockout HT29 Polyclonal Cells Cat. No. ARG14795 GMEB1 Knockout A549 Polyclonal Cells GMEB1 Knockout A549 Polyclonal Cells Cat. No. ARG10305 AR Knockout Jurkat Polyclonal Cells AR Knockout Jurkat Polyclonal Cells Cat. No. ARG23341 ARFGAP3 Knockout MES-OV Polyclonal Cells ARFGAP3 Knockout MES-OV Polyclonal Cells Cat. No. ARG24197 Rat Bladder Smooth Muscle Cell Medium Rat Bladder Smooth Muscle Cell Medium Cat. No. ARM0256
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Urinary bladder
Disease:
Carcinoma (Recurrent)
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
44 years
Sex of Donor:
Male
Derived From Site:
In situ; Urinary bladder
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CALML3 Knockout HAP1 Polyclonal Cells

CALML3 Knockout HAP1 Polyclonal Cells

Cat. No. ARG34567
 C2orf76 Knockout A2780 Polyclonal Cells

C2orf76 Knockout A2780 Polyclonal Cells

Cat. No. ARG28959
 ALLC Knockout HAP1 Polyclonal Cells

ALLC Knockout HAP1 Polyclonal Cells

Cat. No. ARG21784
 GPSM1 Knockout SK-HEP-1 Polyclonal Cells

GPSM1 Knockout SK-HEP-1 Polyclonal Cells

Cat. No. ARG32502
 CAP2 Knockout MES-OV Polyclonal Cells

CAP2 Knockout MES-OV Polyclonal Cells

Cat. No. ARG42143
 MSH5 Knockout Hela Polyclonal Cells

MSH5 Knockout Hela Polyclonal Cells

Cat. No. ARG7531